Delivery Order SPE2DR25D3301-SPE2DR26F19CR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,894.39 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials on November 18, 2025, with completion targeted for November 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through DLA's pharmaceutical procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials with a ceiling value of $5,165.40. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's larger pharmaceutical supply vehicle with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials, with a ceiling value of $40,702.19. The award, issued on November 14, 2025, is a firm fixed price delivery order with an ultimate completion date of November 17, 2025. This contract represents a non-competitive set-aside award, indicating the vendor was selected through open competition to supply this specialized pharmaceutical product. Performance will be...
- The Defense Logistics Agency awarded a $9,667.42 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract utilizes firm fixed price pricing with a completion date of September 16, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs this delivery order from its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials. This is a competitively awarded, firm fixed-price contract with no set-aside designation and a ceiling value of $11,438.76. The delivery order is scheduled for completion by October 31, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under...
- The Defense Logistics Agency awarded a $1,351.00 delivery order to AmerisourceBergen Drug Corp for Ferumoxytol 510 mg/17 mL vials on November 5, 2025, with completion expected by November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials. This is a firm fixed-price contract with a ceiling value of $2,349.10 and an ultimate completion date of June 27, 2025. The contract is not set-aside and represents a competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials with a firm fixed price ceiling value of $4,988.61. This is a non-set-aside competitively awarded delivery order with an ultimate completion date of November 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,652.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This firm fixed-price, competitively awarded contract was executed on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $25,204.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials, with an ultimate completion date of June 2, 2025. The award was announced on May 30, 2025, and represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19CRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,988.34 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open procurement. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. This delivery order represents a relatively short-term pharmaceutical supply arrangement supporting federal medical procurement needs. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle running through December 2026 that enables comprehensive global pharmaceutical support to military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent track record of competitively awarded delivery orders demonstrates its capability to meet federal medical supply requirements across varying order values and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 12/7/25 |